Related Experiment Video
Updated: May 5, 2026

The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Is intra-aortic balloon pump absolutely contraindicated in type A aortic dissection?
N Jaussaud1, M Durand, A Boignard
1Department of Cardiac Surgery, Timone University Hospital, Marseille, France - OChavanon@chu-grenoble.fr.
Insights
Intra-aortic balloon pump (IABP) use in severe cardiogenic shock after type A aortic dissection surgery is a salvage option. While associated with high mortality, IABP did not cause aortic rupture or dissection extension in this patient group.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Intensive Care Medicine
Background:
- Circulatory failure post-type A aortic dissection surgery carries high mortality.
- Intra-aortic balloon pump (IABP) is typically contraindicated in aortic dissection.
- Severe cardiogenic shock necessitates advanced circulatory support.
Purpose of the Study:
- To evaluate the short and midterm outcomes of IABP use in patients with severe cardiogenic shock following type A aortic dissection surgery.
- To assess the safety and efficacy of IABP as a salvage therapy in this high-risk population.
Main Methods:
- A retrospective analysis of 10 patients who received postoperative IABP after type A aortic dissection repair between January 2000 and April 2008.
- Details on IABP placement, duration, and complications were recorded.
- Patient outcomes, including mortality, IABP weaning, dissection extension, and neurological sequelae, were analyzed.
Main Results:
- Four of the 10 patients died, with no deaths directly attributed to IABP.
- Eight patients were successfully weaned off IABP due to hemodynamic improvement.
- No instances of IABP-related aortic rupture or dissection extension were observed; however, two patients had device-related complications and six required renal support.
Conclusions:
- IABP can be considered a salvage option for severe cardiogenic shock post-type A aortic dissection surgery.
- The study found no evidence of device-related aortic rupture or dissection extension.
- High mortality and morbidity underscore the critical condition of these patients, emphasizing the need for careful consideration of IABP use.
Aim:
Circulatory failure following surgery for type A aortic dissection is frequent and associated with a high mortality rate. The intra-aortic balloon pump (IABP) is used to treat postcardiotomy cardiogenic shock but aortic dissection is traditionally a contraindication. In 10 patients we used IABP for severe cardiogenic shock following aortic dissection surgery, here we report on the short and midterm results.
Methods:
From January 2000 to April 2008, among 151 patients with type A aortic dissection 10 received a postoperative IABP. False lumen extension was limited to the ascending aorta for 3 patients, reached the arch for 1 and the descending aorta for 6.
Results:
The device was placed in the operative room (7 patients), intensive care unit (2) and preoperatively (1). IABP was introduced percutaneously except for one who required surgical placement. The mean duration of IABP therapy was 3.8 days. Four patients died, but no death was directly related to IABP. Improvement in hemodynamics allowed 8 patients to be weaned off IABP. None suffered extension of the dissection. Two patients developed IABP-related complications. Six required extrarenal purification. Among the survivors, one died of a stroke at 38 months, 2 recovered the same quality of life and 3 had neurological sequelae without loss of autonomy.
Conclusion:
IABP should only be used as a salvage option in cases of severe cardiogenic shock following type A aortic dissection. No patient suffered device-related aortic rupture or extension of the dissection. High mortality and morbidity underline the gravity of cardiogenic shock in this setting.
Related Concept Videos
Aneurysm I: Introduction
Aneurysm IV: Nursing Management
Aortic Regurgitation III: Medical Management
Aneurysm III: Interprofessional Care

